Your browser doesn't support javascript.
loading
Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC-MS/MS.
Yuan, Min; Kremer, Daniel M; Huang, He; Breitkopf, Susanne B; Ben-Sahra, Issam; Manning, Brendan D; Lyssiotis, Costas A; Asara, John M.
Afiliação
  • Yuan M; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Kremer DM; Mass Spectrometry Core, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Huang H; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Breitkopf SB; Graduate Program in Chemical Biology, University of Michigan, Ann Arbor, MI, USA.
  • Ben-Sahra I; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Manning BD; Mass Spectrometry Core, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Lyssiotis CA; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Nat Protoc ; 14(2): 313-330, 2019 02.
Article em En | MEDLINE | ID: mdl-30683937
ABSTRACT
Targeted tandem mass spectrometry (LC-MS/MS) has been extremely useful for profiling small molecules extracted from biological sources, such as cells, bodily fluids and tissues. Here, we present a protocol for analysing incorporation of the non-radioactive stable isotopes carbon-13 (13C) and nitrogen-15 (15N) into polar metabolites in central carbon metabolism and related pathways. Our platform utilizes selected reaction monitoring (SRM) with polarity switching and amide hydrophilic interaction liquid chromatography (HILIC) to capture transitions for carbon and nitrogen incorporation into selected metabolites using a hybrid triple quadrupole (QQQ) mass spectrometer. This protocol represents an extension of a previously published protocol for targeted metabolomics of unlabeled species and has been used extensively in tracing the metabolism of nutrients such as 13C-labeled glucose, 13C-glutamine and 15N-glutamine in a variety of biological settings (e.g., cell culture experiments and in vivo mouse labelling via i.p. injection). SRM signals are integrated to produce an array of peak areas for each labelling form that serve as the output for further analysis. The processed data are then used to obtain the degree and distribution of labelling of the targeted molecules (termed fluxomics). Each method can be customized on the basis of known unlabeled Q1/Q3 SRM transitions and adjusted to account for the corresponding 13C or 15N incorporation. The entire procedure takes ~6-7 h for a single sample from experimental labelling and metabolite extraction to peak integration.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isótopos de Carbono / Glucose / Glutamina / Marcação por Isótopo / Mieloma Múltiplo / Isótopos de Nitrogênio Limite: Animals / Humans Idioma: En Revista: Nat Protoc Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Isótopos de Carbono / Glucose / Glutamina / Marcação por Isótopo / Mieloma Múltiplo / Isótopos de Nitrogênio Limite: Animals / Humans Idioma: En Revista: Nat Protoc Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos